閃耀光彩的必需營養素
70%
超過70%的香港人缺乏維他命 D 維他命 D 在骨骼、心臟和免疫健康中扮演著重要角色,並與維他命K共同作用,以支持鈣的吸收和保持健康的動脈。
600IU
維他命D(每食用份量)

維他命D3(膽鈣化醇)
維他命D促進腸道更有效率地吸收鈣質,主要在十二指腸與空腸內,促進鈣結合蛋白的合成,以支援鈣質正常吸收及保留。維他命D亦促進骨骼正常生成及生長,並且透過成骨細胞與蝕骨細胞促進骨骼再生。

產品分類

不含麩質

素食產品

等滲透傳輸

符合品質標準(GMP)

不含可檢測出之基改成分
如何飲用才能達到最佳效果

將一小瓶蓋(3.3克)的Isotonix粉末倒入杯中。

加入60毫升的水,攪拌後飲用。

每天喝一份。隨餐服用以獲得最佳吸收。
Key Ingredients & Benefits

維他命D3(膽鈣化醇)
促進強健骨骼外,支援身體神經肌肉功能和免疫功能的正常調節

維他命K2(甲萘醌-7)
維持適當地運用體內的鈣,進而確保有足夠的鈣質代謝以支援動脈與骨骼健康
不只強健骨骼
Isotonix維他命D+K2沖飲含有維他命D3,是具代謝活性形式的維他命D,並含有維他命K2,是一種支援血管健康和鈣質運用的維他命K。維他命D對於骨骼健康、心臟健康和免疫支援均有重要作用;與維他命K一同使用,能支援鈣的正常吸收並促進動脈健康。
等滲壓與一般片劑及膠囊比較

5分鐘
等滲壓溶液:
- 快速被身體吸收
- 通過滲透壓增強營養吸收
- 不含人造色素或香料
- 無粘合劑或填充劑阻礙營養釋放
- 效果最大化

40分鐘
一般片劑及膠囊:
- 難以吞嚥
- 身體吸收緩慢
- 維他命和礦物質吸收率降低
- 粘合劑和填充劑阻礙營養釋放
- 通常含有人造色素或香料
常見問題
為何加入維他命K在Isotonix維他命D+K2沖飲?
本產品中加入維他命K因為維他命K和D配合使用成效顯著,能共同支援鈣的吸收和運用。維他命K支援鈣輸送到骨骼,並有助維持動脈健康。
Isotonix維他命D+K2沖飲對服用抗凝血藥物的人是否安全?
研究表示維他命K2不會對抗凝血藥物造成影響。不過,大多數含有維他命K(包括K1及/或K2)的產品都有警告標示,提醒服用抗凝血藥物人士不要使用此類產品。如果你正在服用薄血丸或其他抗凝血藥物,在使用任何含有維他命K1或K2的產品前,請先諮詢你的醫護人員。
如何使用Isotonix維他命D+K2沖飲?
將一小瓶蓋量(白色螺旋蓋)的粉末倒入透明瓶杯中。加水至瓶杯線上(60毫升),攪拌後飲用。作為營養補充品,每日飲用一次,或按你的醫護人員的指示飲用。隨餐一起食用,吸收效果最佳。
每天使用本產品多於一份食用量是否安全?
Isotonix維他命D+K2沖飲建議每日食用一份。如果要食用更多的份量,請先諮詢你的醫護人員。
維他命D可以從哪些食物中攝取?
鱈魚肝油、鮭魚、鯖鱼和吞拿魚皆富含維他命D。
本產品是否標示「不含可檢測出之基因改造生物」?
本產品未檢測出基因改造生物。本產品的原材料中或許含有基因改造的材料/成份,但其最終產品並不含任何轉殖基因片段或轉殖蛋白質。
Isotonix維他命D+K2沖飲安全嗎?
此產品安全並不含有害物質。本產品在美國製造,並經美國食品及藥物管理局檢測設備生產,符合生產規範。
科學資料
科學資料
- Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. International Immunopharmacology. 2(7):1017-1028, 2002.
- American Journal of Epidemiology. 168(8):915-24, 2008. · Deluca H et al. Vitamin D: its role and uses in immunology. FASEB Journal. 15(14):2579-2585, 2001.
- Argiles A et al. Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purification. 20(4):370-375, 2002.
- Bekner K. The vitamin K-dependent carboxylase. Journal of Nutrition. 130(8):1877-1880, 2000.
- Binkley N et al. Vitamin K nutrition and osteoporosis. Journal of Nutrition. 125(7):1812-1821, 1995.
- Bischoff-Ferrari Het al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 293(18):2257-2264, 2005.
- Blackmore K et al. Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer.
- Cantorna M et al. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Experimental Biology and Medicine ( Maywood ). 229(11):1136-1142, 2004.
- Cantorna M. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Society for Experimental Biology and Medicine. 223:230-233, 2000.
- Chapuy M et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine. 327(23):1637-1642, 1992.
- Chlebowski R et al. Vitamin K in the treatment of cancer. Cancer Treatment Review. 12:49-63, 1985.
- Garber, A. K., et al. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. Journal of Nutrition. 129(6):1201-1203, 1999.
- Garland C et al. The role of vitamin D in cancer prevention. American Journal of Public Health. 96(2):252-61, 2006.
- Giovannucci E et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Journal of the National Cancer Institute. 98(7):451-459, 2006.
- Gorham E et al. Vitamin D and prevention of colorectal cancer. Journal Steroid Biochemistry and Molecular Biology. 97(1-2):179-94, 2005.
- Grant W and Holick M. Benefits and requirements of vitamin D for optimal health. Alternative Medicine Review. 10:94-111, 2005.
- Grant W et al. Reviews: A critical review of studies on vitamin D in relation to colorectal cancer. Nutrition and Cancer. 48(2):115-123, 2004.
- Guirguis-Blake J et al. Oral vitamin D3 decreases fracture risk in the elderly. Journal of Family Practice. 52(6):431-435, 2003.
- Gundberg C et al. Vitamin K status and bone health: an analysis of methods for determination under carboxylated osteocalcin. Journal of Clinical Endocrinology and Metabolism. 83(9):3258-3266, 1998.
- Habu D et al. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA. 292(3):358-361, 2004.
- Harris D et al. Vitamin D and colon carcinogenesis. Journal of Nutrition. 134(12):3463S-3471S, 2004.
- Hayes C et al. The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology. 49(2):277-300, 2003.
- Hidaka T et al. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K(2). Journal of Bone and Mineral Metabolism. 20(4):235-239, 2002.
- Hiruma Y et al. Vitamin K(2) and geranylgeraniol, its side chain component, inhibited osteoclast formation in a different manner. Biochemical Biophysical Research Communications. 314(1):24-30, 2004.
- Hitomi M et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. International Journal of Oncology. 26(3):713-720, 2005.
- Holick, M. Vitamin D: Its role in cancer prevention and treatment. Progress in Biophysics and Molecular Biology. 92(1):49-59, 2006.
- Iwamoto J et al. Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design. 10(21):2557-2576, 2004.
- Iwamoto J et al. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. The Keio Journal of Medicine. 2003 Sep;52(3):147-50. Review. · Neogi, T., et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis and Rheumatism. 54(4):1255-1261, 2006.
- Kameda T et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochemical and Biophysical Research Communications. 220(3):515-519, 1996.
- Knapen M et al. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporosis International. 18(7):963-72, 2007.
- Kristal-Boneh E et al. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30(5):1289-1294, 1997.
- Li Y et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation. 110(2):229-238, 2002.
- Li Y et al. Vitamin D regulation of the renin-angiotensin system. Journal of Cell Biochemistry. 88(2):327-331, 2003.
- Li Y et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5):387-392, 2004.
- Nelsestuen G et al. Vitamin K-dependent proteins. Vitamins and Hormones. 58:355-389, 2000.
- Nimptsch K et al. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition. American Journal of Clinical Nutrition. 87:985-992, 2008.
- Nouso K et al. Regression of hepatocellular carcinoma during vitamin K administration. World Journal of Gastroenterology. 11(42):6722-6724, 2005.
- Pfeifer M et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. Journal of Clinical Endocrinology and Metabolism. 86(4):1633-1637, 2001.
- Price P. Role of vitamin K-dependent proteins in bone metabolism. Annual Review of Nutrition. 8:565-583, 1988.
- Schaafsma, A., et al. Vitamin D3 and vitamin K1 supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. European Journal of Clinical Nutrition. 54:626-631, 2000.
- Schleithoff S et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition. 83(4):754-759, 2006.
- Shearer M. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Current Opinion in Clinical Nutrition and Metabolic Care. 3(6):433-438, 2000.
- Shiraki, M., et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. Journal of Bone & Mineral Research. 15:515-522, 2000.
- Sigmund C. Regulation of renin expression and blood pressure by vitamin D(3). Journal of Clinical Investigation. 110(2):155-156, 2002.
- Taira H et al. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors. Calcified Tissue International. 73(1):78-85, 2003.
- Trivedi Det al. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal. 326(7387):469, 2003.
- Van den Berghe G et al. Bone turnover in prolonged critical illness: effect of vitamin D. Journal of Clinical Endocrinology and Metabolism. 88(10):4623-4632, 2003.
- Vasquez A et al. The clinical importance of vitamin D (cholecalciferol): a paradigm shift with implications for all healthcare providers. Alternative Therapies. 10(5):28-38, 2004.
- Weber P. Management of osteoporosis: is there a role for vitamin K? International Journal for Vitamin and Nutrition Research. 67(5):350-6, 1997.
- Yokoyama T et al. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. International Journal of Oncoloy. 26(1):33-40, 2005.
- Yoshida T et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. International Journal of Oncology. 23(3):627-632, 2003.
- Zitterman A et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology. 41(1):105-112, 2003.
Product Label Details
此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲明亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。

評價
顧客評分
4.6 星級評分(滿分為5星)。
(12 評論)
將會推薦此產品。
- 最新
- 最高評價
- 最低評價
- 最舊
- 最有幫助
This is a great product, It helps me every day with more Energy and keeps me going!!!
客戶服務部回覆 日期 6/3/2024
Dear Valued Customer,
Thank you for sharing your positive feedback with us! We're delighted to hear that you're enjoying the Isotonix® Vitamin D with K2 and experiencing the great benefits. Your feedback means a lot to us and it's always great to receive such kind words. If you have any questions or need further assistance, feel free to reach out to us anytime.
Thank you again,
The Product Information Team
Frist time using this and I just love it.
作者 SharonS
日期 16/2/2023
Love this product and i can see the different right away, and it taste good.
客戶服務部回覆 日期 17/2/2023
Dear Valued Customer,
Thank you for taking the time to share your thoughts on the Isotonix® Vitamin D with K2! We are so happy to hear you are pleased with the product!
Thank you again!
The Product Information Team
消費者認為此評論有幫助
For those who don't like to go under the sun.
作者 EShop
購物顧問
日期 16/6/2022
I love this D3 with K2 suppliment very much, as i hate to go under the sun and always stay in door, so i started this vit D for awhile.
When i went for a routine body check-up, my doctoc said that my D vit showed better then him. :)
Love the taste too.
客戶服務部回覆 日期 16/6/2022
Dear Valued Customer,
Thank you for taking the time to leave your thoughts on the Isotonix® Vitamin D with K2. We are happy to hear you are pleased with the product.
Thank you again! Market Singapore Product Team
Must Get!
作者 BrianV
購物顧問
日期 10/5/2022
One of my favorite products, tastes great, doesn't cake up. must try!
客戶服務部回覆 日期 11/5/2022
Dear Valued Customer,
Thank you for taking the time to share your thoughts on the Isotonix® Vitamin D with K2! We are so happy to hear you are pleased with the product!
Thank you again!
The Product Information Team
消費者認為此評論有幫助
食用時間
作者 匿名
日期 5/5/2022
這罐一定要空腹喝嗎?能否餐後?(查到維生素D任何時間服用都可以,餐後喝效果最好)
客戶服務部回覆 日期 16/5/2022
感謝您聯絡美安公司。愛尚它®維生素D3 (含維生素K2)粉末建議用餐時飲用。提供您參考,謝謝您。
消費者認為此評論有幫助
Share this page!
複製此連結並貼上到你喜愛的社交媒體、網誌或網站。
成功!你已複製連結至你的剪貼簿
There was an error copying to your clipboard. Please try again later.